{
    "2020-04-16": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Eli Lilly Still Within Buy Range As Quarterly Report Nears",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "buy range",
                        "quarterly report"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "earnings growth",
                        "buy"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "Roche Most Innovative, Astra Zeneca Most Inventive",
                "features": {
                    "keywords": [
                        "Roche",
                        "Astra Zeneca",
                        "innovative",
                        "inventive"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-06",
                "original_text": "Lower-priced versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® now available",
                "features": {
                    "keywords": [
                        "Humalog",
                        "lower-priced",
                        "versions",
                        "available"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}